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Background: It has been reported that post-stenting no-reflow is associated with thin cap fibroatheroma defined by virtual histology-intravascular 
ultrasound (VH-TCFA) in patients with acute coronary syndrome (ACS), however it is unclear why stent deployment of VH-TCFA area can induce no-
reflow phenomenon. To clarify the above-mentioned mechanism, we examined the correlation between stenting in VH-TCFA area and histology of 
retrieved material using filter and thrombectomy in ACS.
Methods: Fifty consecutive ACS patients who received VH-IVUS-guided coronary intervention with distal protection filter device and thrombectomy 
were enrolled. We divided our patients into VH-TCFA group in whom VH-TCFA was found before stent deployment and non VH-TCFA group in whom VH-
TCFA was not found. We compared the incidence of filter no-reflow (FNR), histology of retrieved material between the two groups.
Results: The incidence of FNR and atheromatous substances in the retrieved material was significantly higher in VH-TCFA group than non VH-TCFA 
group (table). On the retrieved material, atheromatous substances tended to induce FNR more frequently than only fibrinous clot or thrombus. After 
removing the filter, no patients show slow or no-reflow phenomenon.
Conclusion: Stent deployment of VH-TCFA area may frequently produce atheromatous substances which can induce no-reflow phenomenon. The 
filter protection device should be used if VH-TCFA is found before stenting. 
VH-TCFA group
(n=17)
non-VH-TCFA group
(n=33)
p value
Age (years old) 66.9±3.1 70.8±1.8 0.25
Left main trunk/Left anterior descending aretry/Left circumflex artery/
Right coronary artery, n (%)
0/9/1/7 (0/52.9/5.9/41.2) 1/15/2/15 (3.0/45.5/6.0/45.5) 0.87
Filter no-reflow phenomenon, n (%) 17 (100.0) 11 (33.3) <0.01
Material included atheromatous substances in addition to fibrinous 
clot or thrombus. n (%)
11 (64.7) 1 (3.0) <0.01
Material included only fibrinous clot or thrombus. n (%) 6 (35.3) 32 (97.0) <0.01
